Difference of binding modes among three ligands to a receptor mSin3B corresponding to their inhibitory activities

Abstract A preceding experiment suggested that a compound, which inhibits binding of the REST/NRSF segment to the cleft of a receptor protein mSin3B, can be a potential drug candidate to ameliorate many neuropathies. We have recently developed an enhanced conformational sampling method, genetic-algo...

Full description

Bibliographic Details
Main Authors: Tomonori Hayami, Narutoshi Kamiya, Kota Kasahara, Takeshi Kawabata, Jun-ichi Kurita, Yoshifumi Fukunishi, Yoshifumi Nishimura, Haruki Nakamura, Junichi Higo
Format: Article
Language:English
Published: Nature Portfolio 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-85612-9
_version_ 1818460361764896768
author Tomonori Hayami
Narutoshi Kamiya
Kota Kasahara
Takeshi Kawabata
Jun-ichi Kurita
Yoshifumi Fukunishi
Yoshifumi Nishimura
Haruki Nakamura
Junichi Higo
author_facet Tomonori Hayami
Narutoshi Kamiya
Kota Kasahara
Takeshi Kawabata
Jun-ichi Kurita
Yoshifumi Fukunishi
Yoshifumi Nishimura
Haruki Nakamura
Junichi Higo
author_sort Tomonori Hayami
collection DOAJ
description Abstract A preceding experiment suggested that a compound, which inhibits binding of the REST/NRSF segment to the cleft of a receptor protein mSin3B, can be a potential drug candidate to ameliorate many neuropathies. We have recently developed an enhanced conformational sampling method, genetic-algorithm-guided multi-dimensional virtual-system-coupled canonical molecular dynamics, and in the present study, applied it to three systems consisting of mSin3B and one of three compounds, sertraline, YN3, and acitretin. Other preceding experiments showed that only sertraline inhibits the binding of REST/NRSF to mSin3B. The current simulation study produced the spatial distribution of the compounds around mSin3B, and showed that sertraline and YN3 bound to the cleft of mSin3B with a high propensity, although acitretin did not. Further analyses of the simulation data indicated that only the sertraline–mSin3B complex produced a hydrophobic core similar to that observed in the molecular interface of the REST/NRSF-mSin3B complex: An aromatic ring of sertraline sunk deeply in the mSin3B’s cleft forming a hydrophobic core contacting to hydrophobic amino-acid residues located at the bottom of the cleft. The present study proposes a step to design a compound that inhibits competitively the binding of a ligand to its receptor.
first_indexed 2024-12-14T23:29:02Z
format Article
id doaj.art-2898f8cc3360474e8e56e88ebf1a1694
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T23:29:02Z
publishDate 2021-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-2898f8cc3360474e8e56e88ebf1a16942022-12-21T22:43:44ZengNature PortfolioScientific Reports2045-23222021-03-0111111210.1038/s41598-021-85612-9Difference of binding modes among three ligands to a receptor mSin3B corresponding to their inhibitory activitiesTomonori Hayami0Narutoshi Kamiya1Kota Kasahara2Takeshi Kawabata3Jun-ichi Kurita4Yoshifumi Fukunishi5Yoshifumi Nishimura6Haruki Nakamura7Junichi Higo8Institute for Protein Research, Osaka UniversityGraduate School of Simulation Studies, University of HyogoCollege of Life Sciences, Ritsumeikan UniversityInstitute for Protein Research, Osaka UniversityGraduate School of Medical Life Science, Yokohama City UniversityCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST)Graduate School of Medical Life Science, Yokohama City UniversityInstitute for Protein Research, Osaka UniversityInstitute for Protein Research, Osaka UniversityAbstract A preceding experiment suggested that a compound, which inhibits binding of the REST/NRSF segment to the cleft of a receptor protein mSin3B, can be a potential drug candidate to ameliorate many neuropathies. We have recently developed an enhanced conformational sampling method, genetic-algorithm-guided multi-dimensional virtual-system-coupled canonical molecular dynamics, and in the present study, applied it to three systems consisting of mSin3B and one of three compounds, sertraline, YN3, and acitretin. Other preceding experiments showed that only sertraline inhibits the binding of REST/NRSF to mSin3B. The current simulation study produced the spatial distribution of the compounds around mSin3B, and showed that sertraline and YN3 bound to the cleft of mSin3B with a high propensity, although acitretin did not. Further analyses of the simulation data indicated that only the sertraline–mSin3B complex produced a hydrophobic core similar to that observed in the molecular interface of the REST/NRSF-mSin3B complex: An aromatic ring of sertraline sunk deeply in the mSin3B’s cleft forming a hydrophobic core contacting to hydrophobic amino-acid residues located at the bottom of the cleft. The present study proposes a step to design a compound that inhibits competitively the binding of a ligand to its receptor.https://doi.org/10.1038/s41598-021-85612-9
spellingShingle Tomonori Hayami
Narutoshi Kamiya
Kota Kasahara
Takeshi Kawabata
Jun-ichi Kurita
Yoshifumi Fukunishi
Yoshifumi Nishimura
Haruki Nakamura
Junichi Higo
Difference of binding modes among three ligands to a receptor mSin3B corresponding to their inhibitory activities
Scientific Reports
title Difference of binding modes among three ligands to a receptor mSin3B corresponding to their inhibitory activities
title_full Difference of binding modes among three ligands to a receptor mSin3B corresponding to their inhibitory activities
title_fullStr Difference of binding modes among three ligands to a receptor mSin3B corresponding to their inhibitory activities
title_full_unstemmed Difference of binding modes among three ligands to a receptor mSin3B corresponding to their inhibitory activities
title_short Difference of binding modes among three ligands to a receptor mSin3B corresponding to their inhibitory activities
title_sort difference of binding modes among three ligands to a receptor msin3b corresponding to their inhibitory activities
url https://doi.org/10.1038/s41598-021-85612-9
work_keys_str_mv AT tomonorihayami differenceofbindingmodesamongthreeligandstoareceptormsin3bcorrespondingtotheirinhibitoryactivities
AT narutoshikamiya differenceofbindingmodesamongthreeligandstoareceptormsin3bcorrespondingtotheirinhibitoryactivities
AT kotakasahara differenceofbindingmodesamongthreeligandstoareceptormsin3bcorrespondingtotheirinhibitoryactivities
AT takeshikawabata differenceofbindingmodesamongthreeligandstoareceptormsin3bcorrespondingtotheirinhibitoryactivities
AT junichikurita differenceofbindingmodesamongthreeligandstoareceptormsin3bcorrespondingtotheirinhibitoryactivities
AT yoshifumifukunishi differenceofbindingmodesamongthreeligandstoareceptormsin3bcorrespondingtotheirinhibitoryactivities
AT yoshifuminishimura differenceofbindingmodesamongthreeligandstoareceptormsin3bcorrespondingtotheirinhibitoryactivities
AT harukinakamura differenceofbindingmodesamongthreeligandstoareceptormsin3bcorrespondingtotheirinhibitoryactivities
AT junichihigo differenceofbindingmodesamongthreeligandstoareceptormsin3bcorrespondingtotheirinhibitoryactivities